David Lawrence

5.7k citations
74 papers · 3.3k · 1 hit paper · h-index 29

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research

Papers in

David Lawrence

73 papers receiving 3.3k citations

David Lawrence's Hit Papers

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. 1998 · 509 citations
5090+9+18Years since publication100200300400500

Peers

David Lawrence
Comparison fields: 5 of 98
  • Hematology 1.5k
  • Genetics 679
  • Pathology and Forensic Medicine 422
  • Pulmonary and Respiratory Medicine 670
  • Oncology 471
Replace James K. Weick with:
James K. Weick United States
Lloyd E. Damon United States
Dominic Culligan United Kingdom
Sanford Kempin United States
Enrico Maria Pogliani Italy
Lawrence A. Solberg United States
Michael J. Barnett Canada
Minnie Abromowitch United States
Yves Pérel France
Chul Won Choi South Korea
David Lawrence relative to James K. Weick United States James K. Weick's profile →
Citations per field
00.5×2.6×
James K. Weick · 1×
Citations per year

Countries citing papers authored by David Lawrence

Since Specialization
Citations

This map shows the geographic impact of David Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lawrence more than expected).

Fields of papers citing papers by David Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lawrence. The network helps show where David Lawrence may publish in the future.

Co-authors

The 25 scholars most cited alongside David Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Lawrence Line = papers co-authored together David Lawrence links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Hit paper breakdown →
1998509
2 2006314
3 1997180
4 2005177
5 1997176
6
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
1998169
7 1989135
8 1997125
9
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
199891
10 199790
11 200083
12 199980
13 201070
14 201067
15
Therapy of locally recurrent renal cell carcinoma after nephrectomy.
199661
16 200756
17 199656
18 199854
19 199050
20
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.
199848

About David Lawrence

David Lawrence is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Hematology, Oncology and Molecular Biology, having authored 74 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (11 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Renal cell carcinoma treatment (6 papers), Virus-based gene therapy research (4 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (679 citations), Pathology and Forensic Medicine (422 citations), Pulmonary and Respiratory Medicine (670 citations) and Oncology (471 citations). David Lawrence has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Charles A. Schiffer, Clara D. Bloomfield, John C. Byrd, Frederick R. Davey, Andrew J. Carroll, Ramana Tantravahi, Robert J. Mayer, Mark J. Pettenati, D Arthur and Maria R. Baer. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Journal of Urology, The Lancet and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact